The Sergeant First Class Heath Robinson Honoring our Promise to Address Comprehensive Toxics (PACT) Act expanded VA health-care eligibility, exposure documentation, and presumptive service-connection paths. It did not create one universal “burn-pit claim.” The statute and regulations contain several lanes with different locations, dates, diagnoses, and manifestation rules. Match the lane to the service record before assuming a presumption applies. Claim Raven's presumptive-conditions tool and Pathfinder are screening tools, not automatic eligibility decisions.

Keep the lanes separate

The PACT Act's core statutory group is in 38 U.S.C. §§ 1119–1120. The group 1 covered countries have service on or after August 2, 1990. The group 2 covered countries have service on or after September 11, 2001. Section 1119 group 1 includes Bahrain, Iraq, Kuwait, Oman, Qatar, Saudi Arabia, Somalia, and the United Arab Emirates, including airspace. Section 1119 group 2 includes Afghanistan, Djibouti, Egypt, Jordan, Lebanon, Syria, Yemen, Uzbekistan, and any other country the Secretary later determines relevant under § 1119(c)(1)(B)(ix), including airspace. The service-location and diagnosis rules in §§ 1119–1120 still matter; a deployment outside the statutory list does not become a PACT presumption merely because it involved a burn pit.

The separate 38 CFR § 3.320 lane covers asthma, rhinitis, sinusitis, and specified rare respiratory cancers. Its service rule covers the Southwest Asia theater during the Persian Gulf War. It also names Afghanistan, Syria, Djibouti, and Uzbekistan only for service on or after September 19, 2001. That September 19, 2001 rule is different from the September 11, 2001 statutory group in §§ 1119–1120. For § 3.320, the Southwest Asia theater includes Iraq, Kuwait, Saudi Arabia, the neutral zone, Bahrain, Qatar, the United Arab Emirates, Oman, the Gulf of Aden, the Gulf of Oman, the Persian Gulf, the Arabian Sea, the Red Sea, and airspace above the listed locations.

For the related 38 CFR §§ 3.320a–3.320b lanes, the 1990 group is the Southwest Asia theater and Somalia, including airspace above both. That theater includes the Gulf of Aden, Gulf of Oman, Persian Gulf, Arabian Sea, and Red Sea. The 2001 group includes Afghanistan, Djibouti, Egypt, Jordan, Lebanon, Syria, Yemen, and Uzbekistan, including airspace, with the applicable date beginning September 11, 2001. These regulations are condition-specific; use the exact subsection and diagnosis rather than treating all “toxic exposure” conditions as interchangeable.

Afghanistan service in 1995 is a different screen

Afghanistan service in 1995 may fit the separate Gulf War qualifying-chronic-disability framework in 38 U.S.C. § 1117 and 38 CFR § 3.317. It does not satisfy the later Afghanistan date requirements in §§ 1119–1120 or in 38 CFR §§ 3.320, 3.320a, and 3.320b. This distinction prevents a veteran from being screened out of a § 1117 claim merely because the later burn-pit dates do not fit, and it prevents a § 1117 location from being mislabeled as a PACT § 1120 presumption.

The § 1117 rule is also the diagnosis exception: a Gulf War undiagnosed-illness claim can use objective indications of a chronic disability that cannot be attributed to a known clinical diagnosis. Qualifying service includes the Southwest Asia theater—such as Iraq, Kuwait, Saudi Arabia, the neutral zone between Iraq and Saudi Arabia, Bahrain, Qatar, the United Arab Emirates, Oman, the Gulf of Aden, the Gulf of Oman, the Persian Gulf, the Arabian Sea, the Red Sea, and airspace above those locations—and separately named service in Afghanistan, Israel, Egypt, Turkey, Syria, and Jordan. The infectious-disease branch in § 3.317(c) has narrower locations and timing; it is not the same as the broad chronic-disability branch. See Chapter 11: Secondary and Presumptive Conditions.

Conditions in the PACT Act lanes

Ten cancer categories and glioblastoma in § 1120

Section 1120 lists ten cancer categories: head cancer of any type, neck cancer of any type, respiratory cancer of any type, gastrointestinal cancer of any type, reproductive cancer of any type, lymphoma cancer of any type, kidney cancer, brain cancer, melanoma, and pancreatic cancer. It lists glioblastoma separately. Confirm the diagnosis and the applicable covered-service facts rather than assuming that every tumor near one of those body systems is classified the same way.

Twelve non-cancer illnesses in § 1120

The statutory § 1120 list includes these twelve non-cancer respiratory illnesses when the applicable covered-service and diagnosis requirements are met:

  • Asthma
  • Chronic Bronchitis
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Emphysema
  • Granulomatous Disease
  • Interstitial Lung Disease
  • Pleuritis
  • Pulmonary Fibrosis
  • Sarcoidosis
  • Chronic Sinusitis
  • Chronic Rhinitis
  • constrictive or obliterative bronchiolitis

The regulation may use related diagnostic terminology, such as chronic rhinosinusitis or separate constrictive and obliterative bronchiolitis findings. A medical record should identify the actual diagnosis and objective testing. A symptom such as shortness of breath is not, by itself, one of the listed illnesses. Conversely, a named illness can still require evidence that the statutory service and post-service diagnosis rules are met.

Nine exact rare respiratory cancers in § 3.320

The § 3.320 rare-respiratory-cancer list is narrow. The exact diagnoses are:

  1. Squamous Cell Carcinoma of the Larynx
  2. Squamous Cell Carcinoma of the Trachea
  3. Adenocarcinoma of the Trachea
  4. Salivary Gland-Type Tumor of the Trachea
  5. Salivary Gland-Type Tumor of the Lung
  6. Adenosquamous Carcinoma of the Lung
  7. Large Cell Carcinoma of the Lung
  8. Sarcomatoid Carcinoma of the Lung
  9. Typical and Atypical Carcinoid of the Lung

The histology and anatomical site in the pathology report matter. Broad labels such as “lung cancer” may require VA to determine whether the exact regulatory category is met; other cancers may be claimable through a different statutory, direct, or TERA theory. Do not replace the exact list with a generic cancer list.

Other current PACT-related regulatory categories include urinary bladder cancer, including overlapping sites of the bladder; ureter cancer, including the ureteric orifice and urachus; acute and chronic leukemias; multiple myelomas, including monoclonal gammopathy of undetermined significance (MGUS); myelodysplastic syndromes; and myelofibrosis under §§ 3.320a–3.320b. Confirm the applicable subsection and current text before filing because the disease list and aliases are easy to misread.

Exposure evidence and non-presumptive theories

Covered service can establish the exposure or location element for a qualifying presumption; it does not prove every medical element. Keep DD-214s, personnel records, deployment orders, unit histories, maps, and treatment records. VA's Airborne Hazards and Open Burn Pit Registry is a health resource, not a substitute for a claim or a medical diagnosis. A claim for a condition outside the list may still proceed as direct service connection or under the TERA medical-opinion requirement in 38 U.S.C. § 1168. The TERA chapter explains that path, and Chapter 2: Evidence explains how to organize a nexus and objective testing.

Presumptions also affect timing. Preserve an Intent to File and read the effective-date paragraph in the decision; a PACT Act change does not automatically produce the same date for every veteran. See Chapter 9: Effective Dates and Back Pay. If VA used the wrong country, date, diagnosis, or subsection, identify that specific error in the appropriate appeal lane rather than filing a generic “PACT Act” request.

Official sources